Macrophages are key immune cells in the activation and regulation of immune responses. These cells are present in all tissues under homeostatic conditions and in many disease settings. Macrophages can exhibit a wide range of phenotypes depending on local and systemic cues that drive the differentiation and activation process. Macrophage heterogeneity is also defined by their ontogeny. Tissue macrophages can either derive from circulating blood monocytes or are seeded as tissue‐resident macrophages during embryonic development. In humans, the study of in vivo‐generated macrophages is often difficult with laborious and cell‐changing isolation procedures. Therefore, translatable, reproducible, and robust in vitro models for human macrophages in health and disease are necessary. Most of the methods for studying monocyte‐derived macrophages are based on the use of limited factors to differentiate the monocytes into macrophages. Current knowledge shows that the in vivo situation is more complex, and a wide range of molecules in the tissue microenvironment promote and impact on monocyte to macrophage differentiation as well as activation. In this review, macrophage heterogeneity is discussed and the human in vitro models that can be applied for research, especially for monocyte‐derived macrophages. We also focus on new molecules (IL‐34, platelet factor 4, etc.) used to generate macrophages expressing different phenotypes.
Classic and new mediators for in vitro modelling of human macrophages
Rosario Luque-Martin,P. Mander,P. Leenen,M. Winther
Published 2020 in Journal of Leukocyte Biology
ABSTRACT
PUBLICATION RECORD
- Publication year
2020
- Venue
Journal of Leukocyte Biology
- Publication date
2020-06-27
- Fields of study
Biology, Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
CITED BY
Showing 1-20 of 20 citing papers · Page 1 of 1